You are here

  • Home
  • Archive
  • Volume 68, Issue 3
  • Author's response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study

Article Text

Article menu

Download PDFPDF

PostScript
Correspondence
Author's response: understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study
Free
  1. David Taylor-Robinson1,
  2. Margaret Whitehead1,
  3. Finn Diderichsen2,
  4. Hanne Vebert Olesen3,
  5. Tania Pressler4,
  6. Rosalind Smyth5,
  7. Peter Diggle6
  1. 1Department of Public Health and Policy, University of Liverpool, Liverpool, UK
  2. 2Department of Social Medicine, University of Copenhagen, Copenhagen, Denmark
  3. 3Cystic Fibrosis Center, Aarhus University Hospital, Aarhus, Denmark
  4. 4Cystic Fibrosis Center, Rigshospitalet, Copenhagen, Denmark
  5. 5Institute of Child Health, UCL, London, UK
  6. 6Institute of Infection and Global Health, University of Liverpool, Liverpool, UK
  1. Correspondence to Dr David Taylor-Robinson, Department of Public Health and Policy, University of Liverpool, Liverpool, UK; dctr{at}liv.ac.uk

https://doi.org/10.1136/thoraxjnl-2012-202954

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank Professor Miller for his comments1 regarding our paper,2 in which we outline a novel approach to modelling repeated lung function measures in people with cystic fibrosis (CF) over long follow-up periods. We agree that it would be interesting to apply our methodology using alternative methods of expressing lung function across the age range, and reiterate that our approach can be usefully applied to any clinical …

    View Full Text

    Linked Articles